In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy

In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy

IntroductionTreatment-free remission (TFR) in patients with chronic myeloid leukemia in chronic phase is considered a safe option if suitable molecular monitoring is available. However, the question arises as to which factors can contribute to the maintenance of TFR, and immunologic surveillance of...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: María Belén Sanchez, Bianca Vasconcelos Cordoba, Carolina Pavlovsky, Beatriz Moiraghi, Ana Varela, Rosario Custidiano, Isolda Fernandez, María Josefina Freitas, María Verónica Ventriglia, Georgina Bendek, Romina Mariano, María José Mela Osorio, Miguel Arturo Pavlovsky, Ana García de Labanca, Cecilia Foncuberta, Isabel Giere, Masiel Vera, Mariana Juni, José Mordoh, Julio Cesar Sanchez Avalos, Estrella Mariel Levy, Michele Bianchini
Μορφή: Άρθρο
Γλώσσα:English
Έκδοση: Frontiers Media S.A. 2023-09-01
Σειρά:Frontiers in Immunology
Θέματα:
chronic myeloid leukemia
treatment free remission
NK cells
degranulation
immunophenotype
Διαθέσιμο Online:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1241600/full

Διαδίκτυο

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1241600/full

Παρόμοια τεκμήρια